Meridian Bioscience Inc (VIVO)

18.24 +0.18  +1.00% NASDAQ Oct 20, 15:05 USD
View Full Chart
Price Chart
View All VIVO News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q4 2021 Earnings Results
11/12/2021 10:00 EST Earnings Calls Q4 2021 Earnings Call
08/06/2021 Earnings Results Q3 2021 Earnings Results
08/06/2021 10:00 EST Earnings Calls Q3 2021 Earnings Call
05/07/2021 Earnings Results Q2 2021 Earnings Results
05/07/2021 10:00 EST Earnings Calls Q2 2021 Earnings Call
02/05/2021 Earnings Results Q1 2021 Earnings Results
02/05/2021 10:00 EST Earnings Calls Q1 2021 Earnings Call
01/27/2021 14:00 EST AGM 2020 Annual General Meeting
11/13/2020 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
  • URL: http://www.meridianbioscience.com
  • Investor Relations URL: https://investor.meridianbioscience.com
  • HQ State/Province: Ohio
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 01, 2019

Top Fund Holders

Symbol Name Weighting
F0000171OP ST Small-Cap Opportunities 1 F RE 1.99%
AFMCX Acuitas US Microcap Institutional 1.24%
ROSC Hartford Multifactor Small Cap ETF 0.79%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.